OUD is a medical condition that arises from the regular use of opioids, such as prescription painkillers, heroin, or synthetic opioids. According to the World Health Organization (WHO), OUD affects an estimated 16 million people globally.
The market for OUD treatment includes medications, behavioral therapies, and other supportive services. Some of the commonly used medications for OUD include methadone, buprenorphine, and naltrexone. Behavioral therapies, such as cognitive-behavioral therapy and contingency management, can also be effective in treating OUD.
See the detailed report:
https://www.fortunebusinessinsights.com/opioid-use-disorder-oud-market-102674
The global “Opioid Use Disorder Market” size is expected to reach USD 5.64 billion by 2029, exhibiting a CAGR of 8.9% during the forecast period, states Fortune Business Insights in a report titled “Opioid Use Disorder Market, 2022-2027.” The market size stood at USD 2.88 billion in 2021.
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
• Key Opinion Leaders associated with Infinium Global Research
• Internal and External subject matter experts
• Professionals and participants from the industry
What is the goal of the report?
• The market report presents the estimated size of the market at the end of the forecast period. The report also examines historical and current market sizes.
• During the forecast period, the report analyses the growth rate, market size, and market valuation.
• The report presents current trends in the industry and the future potential of the North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa markets.
• The report offers a comprehensive view of the market based on geographic scope, market segmentation, and key player financial performance
List of Key Players Profiled in the Report:
• Orexo AB (Sweden)
• Titan Pharmaceuticals, Inc. (U.S.)
• Mallinckrodt Pharmaceuticals (U.K.)
• BioDelivery Sciences International Inc. (U.S.)
• Viatris Inc. (Mylan N.V.) (U.S.)
• Hikma Pharmaceuticals PLC (U.K.)
• Camurus (Sweden)
To get more information on the regional analysis of this market, Request a Free sample:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/opioid-use-disorder-oud-market-102674
Reasons for buying this report:
• It offers an analysis of changing competitive scenario.
• For making informed decisions in the businesses, it offers analytical data with strategic planning methodologies.
• Researchers throw light on the dynamics of the market such as drivers, restraints, trends, and opportunities.
• It offers regional analysis of Opioid Use Disorder Market along with business profiles of several stakeholders.
• It offers five-year assessment of this market.
• It helps in understanding the major key product segments.
• It offers massive data about trending factors that will influence the progress of the Market
Table of content:
• Introduction
o Research Scope
o Market Segmentation
o Research Methodology
o Definitions and Assumptions
• Executive Summary
• Market Dynamics
o Market Drivers
o Market Restraints
o Market Opportunities
o Market Trends
Continuous…
About Us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com